Cited by 29Mobile Health and mHealth ApplicationsDiabetes Management and EducationDiabetes Management and Research

Evaluation of mobile applications for patients with diabetes mellitus: A scoping review

Open access
Lee, Jung Lim, Kim, Youngji·2024·Healthcare

Abstract

There has been increasing interest in mobile healthcare for diabetes management. However, there remains limited evidence regarding the effectiveness of these mobile applications (apps). This scoping review aimed to evaluate the clinical effectiveness of mobile diabetes management apps. We used the following search terms: “mobile app”, “mobile application”, and “diabetes”. We included only articles written in English and published between January 2016 and August 2021. We identified two, six, and four articles focused on type 1 diabetes, type 2 diabetes, and both diabetes types, respectively. Five, four, and three of these studies reported on the apps’ functionality, usability, and both, respectively. Our findings indicated that diabetes mobile apps allowed for convenient user experience and improved blood sugar levels in patients with diabetes. Considering these findings, usability must be comprehensively evaluated by using definitions such as the ISO9241-11 usability definition or the mobile application rating scale (MARS) when developing diabetes-related apps. For the feasibility of diabetes mobile apps, we recommend that HbA1C and self-management be included as evaluation variables. Given the increasing importance of continuous management for patients with diabetes, interventions using mobile apps are bound to become effective tools for patient-led self-management.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/healthcare12030368

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Telemedicine supported by mHealth seemed to be more frequently associated with improved glycaemic control, whilst past evidence did not consistently demonstrate a clear benefit of telemedicine on metabolic control.

    “In these cases, telemedicine supported by mHealth seemed to be more frequently associated with improved glycaemic control, whilst past evidence did not consistently demonstrate a clear benefit of telemedicine on metabolic control (7–9).”

    From Impact of digital health on Type 2 diabetes management: a randomised controlled trial of the ‘TreC Diabete’ platform (TELEMECHRON Study) (2025) · cites this paper as [8]

    The Results (§3.2; page unavailable) report significant A1C decreases in several studies of diabetes mobile apps, while the Discussion (§4; page unavailable) notes inconsistent findings across app studies. The review does not compare mHealth-supported telemedicine with telemedicine alone or establish that earlier telemedicine evidence lacked a consistent metabolic-control benefit. (LLM, conf=0.83)

    Experimental — accuracy not yet measured
  • The clinical effectiveness of mHealth tools, including those delivered via telemedicine platforms, remains inconsistent, with some studies showing limited or variable impact on metabolic outcomes.

    “However, the clinical effectiveness of mHealth tools, including those delivered via telemedicine platforms, remains inconsistent, with some studies showing limited or variable impact on metabolic, and in the large majority of cases studies were assessing a single-function application.”

    From Impact of digital health on Type 2 diabetes management: a randomised controlled trial of the ‘TreC Diabete’ platform (TELEMECHRON Study) (2025) · cites this paper as [8]

    The Results (§3.2) report significant A1C reductions in some app studies but a nonsignificant blood-sugar reduction in S12; the Discussion (§4) explicitly describes inconsistent HbA1C findings. The review concerns diabetes mobile apps, not the effectiveness of tools delivered via telemedicine platforms. It also does not support the citing sentence’s claim that a large majority of studies assessed single-function applications. Page numbers are unavailable in our copy. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • Mobile diabetes apps improved blood sugar levels and most showed significant HbA1c reduction (0.3%-1.3% decrease).

    “Mobile diabetes apps improved blood sugar levels and provided convenient user experience; most apps showed significant HbA1c reduction (0.3%-1.3% decrease in most studies)”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Lee, J. L., & Kim, Y.
Affiliations
  • Daejeon University (KR)
  • Kongju National University (KR)
Corresponding author
Kim, Youngji
Venue
Healthcare
Publisher
MDPI AG
Published
2024-01-31
Volume
12
Issue
3
Pages
368
ISSN
2227-9032 (ISSN-L)
OpenAlex
W4391404685
Cited by
29
References
44
Citations by year
2026: 6 · 2025: 17 · 2024: 6
FWCI
2.61
Type
journal article
Language
en
Open access
Locations
  • Healthcare (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
National Research Foundation of Korea (NRF) (NRF-2020R1G1A1102912)
Topics
  • Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
diabetes mellitus, mobile health apps, diabetes management, type 1 diabetes, type 2 diabetes, usability evaluation, glycemic control, HbA1c, patient self-management, Mobile App Rating Scale, ISO 9241-11

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review